Fulcrum Therapeutics Inc (FULC) — Net Asset Momentum
Fulcrum Therapeutics Inc (FULC) recorded a net asset momentum of 3.3% as of December 2024, with net assets of $243.03 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Fulcrum Therapeutics Inc (FULC) shareholders funds for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Fulcrum Therapeutics Inc Net Asset Momentum (2017–2024)
This chart tracks Fulcrum Therapeutics Inc's year-over-year net asset growth across 8 annual reporting periods from 2017 to 2024. The most recent momentum reading is +3.3%, with net assets of $243.03 Million USD as of December 2024. For live market cap and overall valuation, see Fulcrum Therapeutics Inc market cap and net worth.
Annual Net Asset History for Fulcrum Therapeutics Inc (2017–2024)
The table below shows the complete annual net asset history for Fulcrum Therapeutics Inc from 2017 to 2024, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Fulcrum Therapeutics Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $243.03 Million | $260.72 Million | $17.68 Million | ▲ +3.3% |
| 2023 | $235.19 Million | $257.69 Million | $22.50 Million | ▲ +18.2% |
| 2022 | $198.94 Million | $226.69 Million | $27.74 Million | ▼ -6.0% |
| 2021 | $211.54 Million | $235.00 Million | $23.46 Million | ▲ +122.2% |
| 2020 | $95.18 Million | $129.58 Million | $34.40 Million | ▲ +9.2% |
| 2019 | $87.15 Million | $110.44 Million | $23.29 Million | ▲ +14.7% |
| 2018 | $76.00 Million | $85.77 Million | $9.77 Million | ▲ +5648.9% |
| 2017 | $1.32 Million | $4.34 Million | $3.02 Million | — |